Insider · CIK 0001437909
Freda C Lewis-Hall
director
Files at SWTX (SpringWorks Therapeutics, Inc.), PYXS (Pyxis Oncology, Inc.), CDT (CDT Equity Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | CDT CDT Equity Inc. | AGrant or award Common Stock | +35,000 | $0.00 | $0 | 38,466 | Aug 26, 2025 |
| Aug 5, 2025 | CDT CDT Equity Inc. | AGrant or award Stock Option (Right to Buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Aug 26, 2025 |
| Jul 1, 2025 | SWTX SpringWorks Therapeutics, Inc. | DDisposition to issuer Common Stock | -24,727 | - | - | 0 | Jul 2, 2025 |
| Jul 1, 2025 | SWTX SpringWorks Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -29,983 | - | - | 0 | Jul 2, 2025 |
| Jul 1, 2025 | SWTX SpringWorks Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -7,464 | - | - | 0 | Jul 2, 2025 |
| Jul 1, 2025 | SWTX SpringWorks Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -15,318 | - | - | 0 | Jul 2, 2025 |
| Jul 1, 2025 | SWTX SpringWorks Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -13,774 | - | - | 0 | Jul 2, 2025 |
| Jul 1, 2025 | SWTX SpringWorks Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,216 | - | - | 0 | Jul 2, 2025 |
| May 14, 2025 | SWTX SpringWorks Therapeutics, Inc. | AGrant or award Common Stock | +10,060 | $0.00 | $0 | 24,727 | May 15, 2025 |
| Mar 31, 2025 | PYXS Pyxis Oncology, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +36,979 | $0.98 | $36k | 36,979 | Apr 2, 2025 |
| Mar 30, 2025 | CDT CDT Equity Inc. | AGrant or award Common Stock | +47,612 | $0.89 | $42k | 51,991 | Apr 1, 2025 |
| Dec 18, 2024 | CDT CDT Equity Inc. | AGrant or award Stock Option (Right to Buy)derivative | +420,000 | $0.07 | $30k | 420,000 | Dec 20, 2024 |
| Nov 18, 2024 | CDT CDT Equity Inc. | AGrant or award Common Stock | +437,976 | $0.09 | $40k | 437,976 | Nov 20, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.